Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO

Go back to Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
(NASDAQ: GANX) Delayed: 2.12 -0.04 (1.85%)
Previous Close $2.16    52 Week High
Open $2.16    52 Week Low
Day High $2.19    P/E N/A 
Day Low $2.09    EPS
Volume 519,004